Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomarin Pharmaceutical

59.17
+0.35000.60%
Post-market: 59.170.00000.00%17:18 EDT
Volume:1.25M
Turnover:73.78M
Market Cap:11.35B
PE:26.81
High:59.62
Open:58.44
Low:58.00
Close:58.82
Loading ...

BioMarin Pharmaceutical Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
21 Feb

Scotiabank Sticks to Its Hold Rating for BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
20 Feb

Q4 2024 BioMarin Pharmaceutical Inc Earnings Call

Thomson Reuters StreetEvents
·
20 Feb

Truist Financial Sticks to Their Buy Rating for BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
20 Feb

Biomarin Pharmaceutical Inc : Citigroup Raises Target Price to $82 From $81

THOMSON REUTERS
·
20 Feb

BioMarin price target raised to $103 from $99 at BofA

TIPRANKS
·
20 Feb

BioMarin price target raised to $82 from $81 at Citi

TIPRANKS
·
20 Feb

Biomarin Pharmaceutical Inc : Scotiabank Raises Target Price to $80 From $78

THOMSON REUTERS
·
20 Feb

BUZZ-BioMarin rises after Q4 results beat estimates

Reuters
·
20 Feb

Stock Track | BioMarin Pharmaceutical (BMRN) Soars 10.52% in Pre-Market on Record Q4 Results, Strong 2025 Outlook

Stock Track
·
20 Feb

BioMarin Pharmaceutical (BMRN) Gets a Buy from Barclays

TIPRANKS
·
20 Feb

William Blair Sticks to Their Hold Rating for BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
20 Feb

Biomarin Pharmaceutical Inc (BMRN) Q4 2024 Earnings Call Highlights: Record Growth and ...

GuruFocus.com
·
20 Feb

Stock Track | BioMarin Pharmaceutical Stock Soars 9.72% After-Hours on Stellar Q4 Results, Upbeat 2025 Outlook

Stock Track
·
20 Feb

Compared to Estimates, BioMarin (BMRN) Q4 Earnings: A Look at Key Metrics

Zacks
·
20 Feb

BioMarin Pharmaceutical (BMRN) Surpasses Q4 Earnings and Revenue Estimates

Zacks
·
20 Feb

BioMarin Pharmaceutical Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
20 Feb

Stock Track | BioMarin Pharmaceutical Stock Soars 7.83% After-Hours on Strong Q4 Results and Upbeat 2025 Outlook

Stock Track
·
20 Feb

BioMarin: Q4 Earnings Snapshot

Associated Press Finance
·
20 Feb

BioMarin Pharmaceutical (NASDAQ:BMRN) Reports Bullish Q4, Stock Soars

StockStory
·
20 Feb